tim akhurst
机构: Peter MacCallum Cancer Centre
每年引用次数
引用次数
引用: 16,440
H-指数: 64
I10-指数 : 124
出版物: 287
Home Evolving Standards of Care Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung Cancer
Michael MacManus , Tim Akhurst
Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung Cancer
Michael MacManus , Tim Akhurst
Staging of non-small cell lung cancer.
Tim Akhurst
Seminars in Respiratory and Critical Care Medicine 29 ( 3) 248 -260
62
2008
PET Scanning with 18F 2-Fluoro-2-Deoxy-D-glucose (FDG) in patients with melanoma: benefits and limitations
An T Nguyen , Tim Akhurst , Steven M Larson , Daniel G Coit
Clinical Positron Imaging 2 ( 2) 93 -98
32
1999
Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei
Michael P Flood , Joseph C Kong , Toan Pham , Peadar S Waters
European Journal of Surgical Oncology 48 ( 7) 1606 -1613
1
2022
Hybrid PET/CT machines: Optimized PET machines for the new millennium?/Reply
Tim Akhurst , Roland Chisin , Henry N Wagner Jr
The Journal of Nuclear Medicine 41 ( 5) 961 -961
1
2000
Gastrointestinal Imaging-Original Research-Combined CT Colonography and 18F-FDG PET of Colon Polyps: Potential Technique for Selective Detection of Cancer and Precancerous Lesions.
Marc J Gollub , Tim Akhurst , Arnold J Markowitz , Martin R Weiser
AJR-American Journal of Roentgenology 188 ( 1) 130 -138
2007
4C/NUCLEAR IMAGING IN THE DIAGNOSIS AND FOLLOW-UP OF CANCER
Tim Akhurst , Steven M Larson
Surgical Oncology: Contemporary Principles & Practice 235 -235
2001
Preface: Lung Cancer xi
Gang Cheng , Tim Akhurst
Positron emission tomography imaging of colorectal cancer.
S M Larson , T Akhurst
Seminars in Oncology 26 ( 5) 577 -583
36
1999
Association of primary, nodal and total metabolic tumor volume with response assessment and overall survival in non-surgical non-small-cell lung cancer (NSCLC) patients treated by radical chemo-radiotherapy
Michael MacManus , Michael Hofman , Mathias Bressel , Sarah Everitt
The Journal of Nuclear Medicine 59 280 -280
2018
Characteristics and Outcomes of Therapy-Related Myeloid Neoplasms after Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Neoplasm (NEN): A Single Centre Series
K Burbury , M Hofman , P Blombery , D Westerman
Neuroendocrinology 108
2
2019
Inflammatory non-tumor FDG uptake in the lung on early follow-up PET/CT in non-small-cell lung cancer patients treated by chemo-radiotherapy: association with response and overall survival
Michael MacManus , Michael Hofman , Mathias Bressel , Sarah Everitt
The Journal of Nuclear Medicine 59 285 -285
2018
THE ROLE OF (68)GA-DOTA-OCTREOTATE (GATATE) PET/CT IN FOLLOW-UP OF PATIENTS WITH SDH-ASSOCIATED PHEOCHROMOCYTOMA AND PARAGANGLIOMA (PPGL)
M Hofman , T Schenberg , R Hicks , A Iravani
Internal Medicine Journal 48
2018
Induction PRRT With CAPTEM Chemotherapy in a High-risk Population of Metastatic Neuroendocrine Neoplasia (NEN): Balancing Efficacy With Risk
J Ferdinandus , G Kong , Hofman , AS Ravi Kumar
European Journal of Nuclear Medicine and Molecular Imaging 45
2018
Favourable Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) for Treatment of Metastatic Rectal Neuroendocrine Neoplasia (NEN)
A Meirovitz , S Grozinsky-Glasberg , M Hofman , M Michael
Neuroendocrinology 106
1
2018
SELECTIVE MITOGEN ACTIVATED PROTEIN KINASE (MAPK) PATHWAY INHIBITION IN RADIOIODINE REFRACTORY DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE
B Solomon , R Hicks , A Iravani , AR Kumar
Internal Medicine Journal 48
2018
WELL-DIFFERENTIATED NEUROENDOCRINE NEOPLASM (NEN) WITH NO OR LOW (68)GA-DOTATATE AND F-18-FDG-AVIDITY: AN UNDER-RECOGNISED MOLECULAR IMAGING PHENOTYPE AND POTENTIAL MIMICKING PITFALLS
M Hofman , L Zidan , R Hicks , A Iravani
Internal Medicine Journal 49
2019
Theranostic Implication of Molecular Imaging Phenotype of Well-Differentiated Lung Carcinoid by 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
M Michael , R Hicks , A Iravani , T Akhurst
Neuroendocrinology 110
2020
Tumor-specific transcriptional targeting of suicide gene therapy.
J Qiao , M Doubrovin , BV Sauter , Y Huang
Gene Therapy 9 ( 3) 168 -175
113
2002